Investigating how certain peptides form nanopores in cell membranes
Structure and Function of Direct Delivery Peptides
['FUNDING_R01'] · TULANE UNIVERSITY OF LOUISIANA · NIH-10915615
This study is looking at special tiny openings made by peptides that can help deliver medications directly into cells, which could lead to better treatments for patients.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | TULANE UNIVERSITY OF LOUISIANA (nih funded) |
| Locations | 1 site (NEW ORLEANS, UNITED STATES) |
| Trial ID | NIH-10915615 on ClinicalTrials.gov |
What this research studies
This research explores the unique behavior of self-assembled peptide nanopores that create large openings in cell membranes. By examining how these peptides interact with lipids and water, the study aims to uncover new principles of peptide and protein assembly in biological membranes. The approach involves testing various peptide structures to understand their stability and function, which could lead to innovative applications in drug delivery and biotechnology. Patients may benefit from advancements in therapies that utilize these nanopores for targeted medication delivery.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with conditions that could be treated with improved drug delivery systems.
Not a fit: Patients with conditions that do not involve membrane-related drug delivery issues may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new methods for delivering medications directly into cells more effectively.
How similar studies have performed: While the concept of peptide nanopores is being explored, this specific approach to understanding their stability and function is relatively novel and has not been extensively tested.
Where this research is happening
NEW ORLEANS, UNITED STATES
- TULANE UNIVERSITY OF LOUISIANA — NEW ORLEANS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WIMLEY, WILLIAM C — TULANE UNIVERSITY OF LOUISIANA
- Study coordinator: WIMLEY, WILLIAM C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.